Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00286078 · ClinicalTrials.gov registry record · NA

Treatment for Migraines With an Implantable Device

A NA study of Migraine, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
179
Enrollment target
15
Study locations

NCT00286078 is a NA study of Migraine that has completed, run by Boston Scientific Corporation. The registered enrollment target is 179 participants, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (50% lower). The trial reports 15 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00286078, a NA study of Migraine, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
179 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.

Conditions Studied

Interventions

  • DEVICE Precision

Study Locations (15)

Illinois

  • Rush Pain Center - Chicago
  • Diamond Headache Clinic - Chicago

Colorado

  • Mile High Research Center - Denver

Connecticut

  • The New England Center for Headache - Stamford

Georgia

  • Walton Rehabilitation Hospital - Augusta

Massachusetts

  • New England Regional Headache Center - Worcester

Missouri

  • Headache Care Center - Springfield

Nevada

  • Headache Specialists - Las Vegas

New York

  • Albert Einstein College of Medicine - Montefiore Headache Unit - The Bronx

Trial Details

FieldValue
Enrollment Target 179 participants
Start Date 2006-02
Est. Completion 2018-11-07
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT00286078

The ClinicalTrials.gov registry entry for NCT00286078 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (50% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Precision is the first listed.

NCT00286078 reports 15 study locations spanning 14 distinct geographic areas - top geographies include Illinois, Colorado, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00286078 about?

NCT00286078 is a clinical study titled "Treatment for Migraines With an Implantable Device". The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.

What is the current status of trial NCT00286078?

This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2006-02. Estimated completion is 2018-11-07.

What conditions does trial NCT00286078 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT00286078?

The interventions under investigation include: Precision (DEVICE).

Who is sponsoring clinical trial NCT00286078?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00286078 being conducted?

This trial has 15 study locations across Colorado, Connecticut, Georgia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.